Literature DB >> 27731957

A wolf in sheep's clothing? Patients' and healthcare professionals' perceptions of oxygen therapy: An interpretative phenomenological analysis.

Carol A Kelly1, Dave Lynes1, Mary R O'Brien1, Ben Shaw2.   

Abstract

BACKGROUND: Despite emerging evidence and guidelines, poor prescribing and administration of oxygen therapy persists. This study aimed to explore healthcare professionals' (HCPs) and patients' perceptions of oxygen.
DESIGN: Semi-structured interviews with 28 patients and 34 HCPs.
FINDINGS: Three master themes uncovered: oxygen as a panacea, the burden of oxygen and antecedents to beliefs. Patients used oxygen for breathlessness and as an enabler; they were grateful to oxygen and accepted it as part of the disease. HCPs used oxygen because it helps patients; it works; and it makes HCPs feel better. But oxygen is not benign and a burden is evident with potential antecedents to beliefs revealed.
SUMMARY: The findings suggest that a set of fixed beliefs regarding oxygen exist, influenced by several impacting factors. The perception that oxygen is a universal remedy presides, but is, at times, contradictory. These findings will raise awareness of entrenched cultures, influence future educational and research strategies, and inform policy.
© 2016 John Wiley & Sons Ltd.

Entities:  

Keywords:  COPD; healthcare professionals; oxygen; perceptions

Mesh:

Year:  2016        PMID: 27731957     DOI: 10.1111/crj.12571

Source DB:  PubMed          Journal:  Clin Respir J        ISSN: 1752-6981            Impact factor:   2.570


  7 in total

1.  Oxygen Supplementation and Hyperoxia in Critically Ill Cardiac Patients: From Pathophysiology to Clinical Practice.

Authors:  Alexander Thomas; Sean van Diepen; Rachel Beekman; Shashank S Sinha; Samuel B Brusca; Carlos L Alviar; Jacob Jentzer; Erin A Bohula; Jason N Katz; Andi Shahu; Christopher Barnett; David A Morrow; Emily J Gilmore; Michael A Solomon; P Elliott Miller
Journal:  JACC Adv       Date:  2022-08-26

2.  Implementing target range oxygen in critical care: A quality improvement pilot study.

Authors:  Rosie Heartshorne; Jenna Cardell; Ronan O'Driscoll; Tim Fudge; Paul Dark
Journal:  J Intensive Care Soc       Date:  2019-12-13

3.  Perceptions of Hyperoxemia and Conservative Oxygen Therapy in the Management of Acute Respiratory Failure.

Authors:  Brett R Curtis; Kimberly J Rak; Aaron Richardson; Kelsey Linstrum; Jeremy M Kahn; Timothy D Girard
Journal:  Ann Am Thorac Soc       Date:  2021-08

4.  Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline.

Authors:  Susan S Jacobs; Jerry A Krishnan; David J Lederer; Marya Ghazipura; Tanzib Hossain; Ai-Yui M Tan; Brian Carlin; M Bradley Drummond; Magnus Ekström; Chris Garvey; Bridget A Graney; Beverly Jackson; Thomas Kallstrom; Shandra L Knight; Kathleen Lindell; Valentin Prieto-Centurion; Elisabetta A Renzoni; Christopher J Ryerson; Ann Schneidman; Jeffrey Swigris; Dona Upson; Anne E Holland
Journal:  Am J Respir Crit Care Med       Date:  2020-11-15       Impact factor: 21.405

5.  Understanding Clinicians' Perceived Barriers and Facilitators to Optimal Use of Acute Oxygen Therapy in Adults.

Authors:  Joyce L Cousins; Peter A B Wark; Sarah A Hiles; Vanessa M McDonald
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-09-25

6.  Association between long-term oxygen therapy provided outside the guidelines and mortality in patients with COPD.

Authors:  Francois Alexandre; Virginie Molinier; Maurice Hayot; Guillaume Chevance; Gregory Moullec; Alain Varray; Nelly Héraud
Journal:  BMJ Open       Date:  2022-01-11       Impact factor: 2.692

7.  Pragmatic randomised controlled trial of a personalised intervention for carers of people requiring home oxygen therapy.

Authors:  Peter Frith; Ruth Sladek; Richard Woodman; Tanja Effing; Sandra Bradley; Suzanne van Asten; Tina Jones; Khin Hnin; Mary Luszcz; Paul Cafarella; Simon Eckermann; Debra Rowett; Paddy A Phillips
Journal:  Chron Respir Dis       Date:  2020 Jan-Dec       Impact factor: 2.444

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.